Home » High-Quality Health Information » Health Topics » Multiple Myeloma » Study: NCT01359657

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Status:	Recruiting participants
Conditions:	Multiple Myeloma
Interventions:	Biological: Anti-CXCR4 (BMS-936564); Biological: Lenalidomide; Biological: Dexamethasone; Biological: Anti-CXCR4 (BMS-936564); Biological: Bortezomib; Biological: Dexamethasone
Institutions:	Dana-Farber Cancer Institute
Health Topics:	Multiple Myeloma
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012